Claritas Pharmaceuticals, Inc.
CLAZF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,210 | -$21,212 | $6,935 | -$31,863 |
| Dep. & Amort. | $18,014 | $33,329 | $0 | $0 |
| Deferred Tax | -$5,142 | -$11 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $875 | $346 |
| Change in WC | -$5,565 | -$4,393 | $1,117 | -$690 |
| Other Non-Cash | -$12,042 | -$15,121 | -$13,775 | $26,646 |
| Operating Cash Flow | -$309 | -$6,483 | -$4,848 | -$5,561 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | -$10,000 |
| Inv. Purchases | $0 | -$8 | $0 | $0 |
| Inv. Sales/Matur. | $2 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$180 | $0 | $0 |
| Investing Cash Flow | $2 | -$188 | $0 | -$10,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $292 | $0 | $3,981 |
| Stock Issued | $0 | $6,184 | $3,233 | $14,577 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $295 | $0 | -$1,844 | $16 |
| Financing Cash Flow | $295 | $6,476 | $1,389 | $18,574 |
| Forex Effect | -$32 | $0 | $0 | $0 |
| Net Chg. in Cash | -$44 | -$195 | -$3,459 | $3,013 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32 | $227 | $3,686 | $673 |
| End Cash | -$12 | $32 | $227 | $3,686 |
| Free Cash Flow | -$309 | -$6,483 | -$4,848 | -$5,561 |